Cormorant Asset Management, 10% Owner: MoonLake Immunotherapeutics MLTX Buy · Filed 23/10/10

Trade details

Type: Insider buy
Amount: $3,524,456.1
Shares · price: 58,839 sh · $59.90 a share
Held after: 8,494,151 sh
Stock: MoonLake Immunotherapeutics MLTX
Person: Cormorant Asset Management10% Owner
Trade date: 23/10/05
Filed: 23/10/10
Days to filing: 5 days

6 insiders bought this week

Insiders buying this week: 6 insiders
Holding change: +0.7%

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 23/09/05~23/11/04

Cormorant Asset Management's recent trades

Cormorant Asset ManagementOther
SellBright Minds Biosciences
Sell
Bright Minds Biosciences
DRUG
$9.8M
109,331 sh
$9.8M
Filed 04/30
Traded 04/28
Cormorant Asset Management10% Owner
SellCorbus Pharmaceuticals Holdings
Sell
Corbus Pharmaceuticals Holdings
CRBP
$344.1K
30,029 sh
$344.1K
Filed 25/12/15
Traded 25/12/11
Cormorant Asset ManagementOther
SellEyePoint
Sell
EyePoint
EYPT
$942K
60,000 sh
$942K
Filed 25/12/08
Traded 25/12/04
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$25.7M
3,390,943 sh
$25.7M
Filed 25/10/01
Traded 25/09/29
Cormorant Asset ManagementOther
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$18.5M
2,800,000 sh
$18.5M
Filed 25/10/01
Traded 25/09/29

Cormorant Asset Management, 10% Owner — bought $3.5M of MoonLake Immunotherapeutics MLTX · 58,839 sh @ $59.90 | Whalegun